Your browser doesn't support javascript.
loading
Case report: dermatomyositis associated with lung cancer with heterogeneous morphology.
Qin, Yin-Yin; Zhou, Cheng-Zhi; Zhu, Zheng; Guan, Wei-Jie; Lin, Xin-Qing; Liu, Chun-Li; Zhou, Yu-Ming; Wu, Hua; Gu, Ying-Ying; Zhang, De-Hua; Ou-Yang, Ming; Zhong, Nan-Shan; Li, Shi-Yue.
Afiliação
  • Qin YY; State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510120, China.
  • Zhou CZ; State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510120, China.
  • Zhu Z; State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510120, China.
  • Guan WJ; State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510120, China.
  • Lin XQ; State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510120, China.
  • Liu CL; State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510120, China.
  • Zhou YM; State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510120, China.
  • Wu H; State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510120, China.
  • Gu YY; State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510120, China.
  • Zhang DH; State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510120, China.
  • Ou-Yang M; State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510120, China.
  • Zhong NS; State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510120, China.
  • Li SY; State Key Laboratory of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510120, China.
J Thorac Dis ; 9(12): E1110-E1117, 2017 Dec.
Article em En | MEDLINE | ID: mdl-29312776
Dermatomyositis (DM) complicated with non-small cell lung cancer (NSCLC) is not rare, and could rapidly develop into severe lung cancer [performance-status score (PS) between 2 and 4]. Moreover, tumor has remarkable heterogeneity, and it is not possible to properly target treatments in cases of relapse without knowing pathological diagnosis. We retrospectively analyzed the diagnosis and treatment of a patient with DM complicated with NSCLC, which developed into severe lung cancer with heterogeneity of the tumor during chemotherapy. In this report, we addressed that in patients with severe lung cancer, both the cancer and factors associated with exacerbation should be simultaneously managed to reduce the PS score and avoid unnecessary delay. A second biopsy is important for proper management of the tumor with heterogeneity.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article